Weight loss in early Parkinson’s linked to cognitive decline
Oct 20, 2022
Patients with Parkinson’s disease who have weight loss in the first year since diagnosis have a significantly faster decline in Montreal Cognitive Assessment scores.
Monoclonal antibodies no better than placebo for early Parkinson’s disease
Aug 04, 2022
Two studies show a lack of benefit in primary or secondary end points with cinpanemab or prasinezumab versus placebo.